ANALYSIS OF PHARMACOLOGIC APPROACHES ABLE TO RESTORE RKIP FUNCTION IN HEPATOCELLULAR CARCINOMA Poma P., Notarbartolo M., Labbozzetta M., Vivona N., D'Alessandro N. |
IDENTIFICATION OF DRUGS TARGETING LEUKEMIC STEM CELL (LSC) SIGNATURE GENES Ferruzzi L., Mulaw M., Ihme S., Fimognari C., Buske C. |
LONG GLUCOCORTICOID-INDUCED LEUCINE ZIPPER (L-GILZ) ACTS AS A TUMOR SUPPRESSOR BY ACTIVATING P53 Petrillo M., Ayroldi E., Cannarile L., Marchetti M., Ronchetti S., Nocentini G., Riccardi C. |
NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE (NAMPT) INHIBITORS: NOVEL MODULATORS OF CANCER-RELATED INFLAMMATION Travelli C., Morlacchi S., Sica A., Canonico P., Genazzani A. |
CHEMISTRY AND PHARMACOLOGICAL PROPERTIES OF TWO GOLD(I) CARBENE COMPLEXES AS POTENTIAL ANTICANCER AGENTS Nobili S., Messori L., Marchetti L., Massai L., Scaletti F., Guerri A., Landini I., Perrone G., Mini E., Leoni P., Pasquali M., Gabbiani C. |
ON THE CARDIAC SAFETY OF PIXANTRONE IN DOXORUBICIN-TREATED PATIENTS: PHARMACOKINETIC AND METABOLIC CHARACTERIZATIONS IN AN EX VIVO HUMAN MYOCARDIAL STRIP MODEL Salvatorelli E., Menna P., Minotti G. |
THE INTRACELLULAR DEATH PATHWAYS INVOLVED IN ZOLEDRONIC ACID-INDUCED APOPTOSIS OF HUMAN BREAST CANCER CELL LINES Fragni M., Bodei S., Bonini S., Generali D., Bottini A., Spano P., Memo M., Sigala S. |
STRUCTURAL CHARACTERIZATION OF LUNG CANCER XENOGRAFTS FOR THE ASSESSMENT OF THE THERAPEUTIC EFFICACY OF EGFR TARGETING MOLECULES Graiani G., Madeddu D., Gervasi A., Saccani F., Frati C., Cavalli S., Lagrasta C., Falco A., Facchinetti F., Alfieri R., Ampollini L., Lorusso B., Urbanek K., Petronini P., Quaini F. |